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A B S T R A C T
This is the protocol for a review and there is no abstract. The objectives are as follows:
The aim of this review is to compare the effects of HNWL programmes with those of CWL programmes on cardiovascular risk factors
in adults with a BMI greater than 25 kg/m2.
B A C K G R O U N D
Description of the condition
The World Health Organization (WHO) defines cardiovascular
diseases (CVDs) as a collection of conditions affecting the heart
and blood vessels in the body. More individuals die from CVDs
annually than from any other disease, making it the leading cause
of mortality across the globe. It is no longer just a disease of de-
veloped nations, as over 80% of CVD mortality now occurs in
developing countries (WHO 2013). Approximately 17.3 million
people died from CVDs in 2008; this is predicted to rise to 23.3
million by 2030, with CVDs projected to remain the foremost
cause of death globally (WHO 2013).
Cardiovascular events, such as myocardial infarctions and strokes,
are primarily triggered by a blood clot in an artery narrowed by
atherosclerosis, which restricts the flow of blood to the heart or
the brain. They are usually acute events, but the risk of such an
event is attributed to long-term health behaviours. In more than
90% of cases worldwide, the risk of a first myocardial infarction is
related to nine independent, potentially modifiable, risk factors:
an abnormal blood lipid profile, smoking, hypertension, diabetes
mellitus, abdominal obesity, diet, alcohol, physical activity and
psychosocial factors such as depression (Yusuf 2004).
The effect of modifying these risk factors is clearer for some be-
haviours than for others. For example, there is substantial evidence
that smoking cessation (Novello 1999); treatment to reduce blood
pressure, treatment to reduce blood lipids and adequately control
diabetes (Graham 2007); adopting a Mediterranean diet (Estruch
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2013; Rees 2013); and increasing levels of physical fitness (Lee
2011) reduce cardiovascular mortality. However, findings regard-
ing intentional weight loss are less clear. Although a body mass
index (BMI) above 25 kg/m2 is associated with a 23% increased
risk of developing CVD (WHO 2013), limited success at achiev-
ing long-term weight loss, together with repeated attempts to lose
weight followed by weight gain, may not only limit the potential
benefits of weight loss, but may be associated with harm, although
the evidence surrounding this is conflicting.
A 15-year prospective cohort study in 1160 men suggested that
weight fluctuations result in a higher risk of all-cause mortality
compared to steadyweightmaintenance, based on an adjusted haz-
ard rate ratio of 1.86 (95% confidence interval (CI) 1.31 to 2.66).
This study adjusted for pre-existing illness, but did not adjust for
intentionality of weight loss (Rzehak 2007). Two further prospec-
tive studies, which adjusted for intentionality of weight loss, did
not find a significantly higher all-cause mortality rate in those with
a history of severe weight cycling than in those whose weight re-
mained stable (Field 2009; Stevens 2012). A meta-analysis of 26
prospective studies by Harrington 2009 found that intentional
weight loss had a small benefit in obese individuals with comor-
bidities (relative risk (RR) 0.84, 95% CI 0.73 to 0.97). However,
weight loss appeared to be associated with slightly highermortality
in healthy individuals (RR 1.11, 95% CI 1.00 to 1.22) and those
who were overweight but not obese (RR 1.09, 95% CI 1.02 to
1.17). The analysis showed no evidence that weight loss conferred
either benefit or risk in healthy obese individuals. Therefore, the
evidence supporting the benefit of intentional weight loss, partic-
ularly in individuals without comorbidities, or the risk of associ-
ated weight cycling in this population is unclear.
The problem of recurrent weight cycling and the difficulty in
achieving and maintaining weight loss may lie in the complex ae-
tiology of overweight and obesity. Although the concept of energy
balance is simple - when an individual’s energy intake exceeds their
energy expenditure, weight is gained (Söderlund 2009) - the fac-
tors that cause intake to exceed expenditure are varied and com-
plex. They comprise interrelated personal and environmental in-
fluences that were described in the 2007 Foresight report on tack-
ling obesities to cluster into seven themes (Foresight 2007). The
first of these themes, food consumption, encompasses personal
food preferences, food habits and portion control, which may be
either self-determined or influenced by current social norms. Food
production is a theme that encompasses factors such as the avail-
ability of cheap, palatable, energy-dense foods. Demand for these
foods fuels food production, which leads to further societal ac-
ceptance and higher demand, and so the cycle continues. Another
theme is physiological factors, which result from an individual’s
biological and genetic composition. These may, for example, par-
tially determine an individual’s regulatory mechanisms of hunger
and satiety. However, the mechanisms may be overridden by ex-
ternal factors such as the availability of food. Individual physical
activity is another theme and includes individual barriers to en-
gaging in physical activity; for example, learned patterns of activ-
ity, sedentary occupations and commuting needs. Physical activity
environment, also a theme, relates to barriers within the environ-
ment, such as the cost of formal exercise and the perceived safety
of being out alone. Another key theme is individual psychology;
this encompasses stress levels, confidence and self-esteem, and the
associated emotive drive to eat, which again may override phys-
iological mechanisms. The last theme is social psychology. This
is related to the thoughts and opinions that permeate society and
are prevalent in printed media, television and education. For ex-
ample, the societal perception of obesity and pressure related to
body image has psychological consequences of stress and low self-
esteem, and overeating may develop as a coping strategy to deal
with these issues (Foresight 2007).
As the factors that contribute to the development of obesity are
many, multicomponent interventions that tackle several of these
areas have been developed for the effective prevention and man-
agement of obesity, so as to reduce the burden of diseases such as
CVD and diabetes. The National Institute forHealth and Clinical
Excellence (NICE 2006) recommend that interventions for obese
individuals comprise components that address diet and physical
activity, and incorporate behavioural change techniques. It rec-
ommends that individuals should strive to reach and maintain a
realistic target weight loss of 5% to 10% of their original weight
through a weekly weight loss of 0.5 kg to 1 kg (NICE 2006). Al-
though many overweight or obese people are able to lose weight
in this way, however, a large proportion of these people are unable
to maintain these new health behaviours or this weight loss. Sev-
eral meta-analyses of randomised trials (Curioni 2005; McTigue
2003; Turk 2009) have shown that about one-third of weight lost
is regained within one year and almost all of the weight lost is
regained within five years (Katzer 2008). Sometimes, this weight
gain continues; a review of 31 long-term studies found that be-
tween one- and two-thirds of dieters gained more weight than they
had lost originally (Mann 2007).
Lack of a sustained change in weight and, hence, a lack of a re-
duction in long-term chronic disease risk, may be due to an em-
phasis on food restriction. Food restriction can lead to hunger
and feelings of deprivation or preoccupation with food, which in
turn trigger overconsumption. Overconsumption and weight gain
may lead to feelings of low self-esteem, depression and guilt. To
manage feelings of guilt associated with overconsumption, fur-
ther attempts are made to restrict eating, and a cycle of dieting
and bingeing, weight loss and weight gain is perpetuated, with
little long-term gain in risk reduction (Cole 2010; Hawley 2008;
Neumark-Sztainer 2000; Rapoport 2000).
This leads us to question what is the best approach to reducing the
chronic disease risk associated with obesity? Should we continue
to focus on weight loss in all who are overweight or obese, or is
there a possibility that some individuals would achieve a greater
improvement in their cardiovascular risk profile through greater
emphasis being placed on the maintenance of a healthy lifestyle
2Health, not weight loss, focused programmes versus conventional weight loss programmes for cardiovascular risk factors (Protocol)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
and improved psychosocial well being, irrespective of weight loss?
Description of the intervention
Interventions that have beendeveloped to focus on the health gains
of dietary change, physical activity and psychosocial well being in
those who are overweight or obese, rather than on weight loss only,
we have termed ’health, not weight loss, focused’ (HNWL) pro-
grammes. Among these is the Health At Every Size (HAES) pro-
gramme. Randomised controlled trials (RCTs) have shown that
HNWL programmes may have a greater effect on reducing car-
diovascular risk factors, such as improving the blood lipid profile
and blood pressure, and reducing depression, compared with con-
ventional weight loss (CWL) programmes (Bacon 2002; Bacon
2005; Carroll 2007; Gagnon-Girouard 2010; Provencher 2007;
Provencher 2009).
HNWL programmes promote healthy lifestyle change and foster
a positive body image, irrespective of BMI or weight loss success.
Behaviour change techniques help individuals adopt more healthy
food choices and engage in more physical activity, with the en-
joyment of food and exercise as an important focus. Techniques
include cognitive restructuring, and attentive and intuitive eating.
A holistic approach is taken that seeks to address the multifacto-
rial aspects of achieving a healthy lifestyle, including emotional,
spiritual and social needs. Promoting mental well being through
encouraging self-acceptance and promoting feelings of self-worth
are all part of this approach.
CWL programmes include behaviour change techniques that fa-
cilitate adopting a healthy diet and increasing physical activity for
the purpose of achieving a weekly weight loss target (NICE 2006).
The weight loss target is a priority of the interventions, unlike
HNWL programmes, which focus on the benefits of a healthy
lifestyle, improved mental well being and self-acceptance, regard-
less of the amount of weight loss achieved. Any weight loss that
does occur through these changes is a bonus rather than a target.
How the intervention might work
In taking the focus away from weight loss and food restriction,
the HNWL approach engages in a more holistic method of pro-
moting healthy behavioural change. The combination of address-
ing psychological and spiritual, as well as physical, well being may
lead to greater contentment and more-sustained lifestyle changes,
resulting in a greater reduction in cardiovascular risk factors than
CWL programmes. A key element of HNWL is teaching indi-
viduals to think positively about food, and also to recognise and
respond to internal cues, such as hunger and satiety (Bacon 2005).
Responding to internal cues to eat is called intuitive eating (IE).
This helps people to eat in response to genuine hunger and not
to consume food for other reasons (e.g. in response to emotion).
This may work as feelings of satisfaction through eating a healthy
diet replace feelings of deprivation. In addition, recognising the
body’s natural desires for food and working in tune with these
may improve body satisfaction, self-image and mental well being
(Katzer 2008; Miller 2001; Robison 2005).
Why it is important to do this review
As described above, we are aware of several RCTs comparing
HNWL with CWL programmes. While two narrative review pa-
pers have been published (Bacon 2011; King 2007), these do not
use robust quantitative methodology to combine and analyse the
whole body of evidence in this area. To do this, a systematic review
and meta-analysis is needed. A scoping review of the literature
showed that to date no systematic review ormeta-analysis has been
conducted in this area and, as such, no clinical recommendation
for or against the effectiveness of HNWL approaches can bemade.
Undertaking a systematic review with meta-analysis will inform
clinical practice regarding whether HNWL approaches show the
potential to improve cardiovascular risk factors compared with
CWL programmes.
O B J E C T I V E S
The aim of this review is to compare the effects of HNWL pro-
grammes with those of CWL programmes on cardiovascular risk
factors in adults with a BMI greater than 25 kg/m2.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Wewill include RCTs comparingHNWLprogrammeswithCWL
programmes. We will also include cluster randomised trials and
take these different study designs into account in the analysis.
Types of participants
We will include adults, 18 years old and over, with a BMI greater
than 25 kg/m2.
Types of interventions
We will include trials comparing HNWL programmes with CWL
programmes.
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Study group
HNWL programmes
Any programme that promotes an increase in physical activity and
improved healthy eating without a primary focus on weight loss,
whether the intervention is branded HAES or not. The focus will
instead be on improving physical and mental health through ad-
dressing a variety of factors, which may include lifestyle, emo-
tional, social and spiritual factors.
Control group
CWL programmes
Any diet, exercise or behavioural programme, or a combination of
these, focusing on achieving weight loss of between 0.5 kg/week
and 1 kg/week.
We have devised a checklist from the descriptions of interventions
in studies already known to us in order to identify suitable pro-
grammes and differentiate between programme types. We have
paid particular attention to the behaviour change techniques that
are unique to each programme (Table 1).
Types of outcome measures
Our outcome measures are based on seven of the nine main risk
factors described previously (Yusuf 2004). Trials need to include
at least one of these outcome measures. The seven risk factors
chosen are those most typically measured as part of weight man-
agement interventions and exclude the assessment of changes in
the prevalences of smoking and diabetes. Included studies must
have a minimum follow-up period of two months after the end of
treatment.
Primary outcomes
Our primary outcomes are the following physiological markers of
cardiovascular risk:
1. blood lipids;
2. blood pressure;
3. body weight.
In trials using more than one measure for any outcome, we will
prefer the measure with the strictest criteria (e.g. measured over
self-reported weight).
Secondary outcomes
Our secondary outcomes are those risk factors that may mediate
the primary outcomes, but that are also known independent car-
diovascular risk factors. They may include a variety of dimensions
and may be measured in a variety of ways. We will pool together
measures of the same dimension and include only those studies
that have measured these outcomes with validated tools:
1. diet;
2. physical activity;
3. alcohol intake;
4. psychosocial well being;
5. adverse events.
Search methods for identification of studies
Our search for trials will begin in 1970, the time when the concept
of HNWL was first developed.
Electronic searches
Wewill identify trials through systematic searches of the following
bibliographic databases:
• Cochrane Central Register of Controlled Trials
(CENTRAL) on The Cochrane Library;
• MEDLINE (Ovid);
• EMBASE (Ovid);
• PsycINFO (Ovid);
• CINAHL (Ebsco);
• ASSIA (Applied Social Sciences Index and Abstracts).
We will adapt the preliminary search strategy for MEDLINE
(Ovid) (Appendix 1) for use with the other databases. We will
apply the Cochrane sensitivity-maximising RCT filter (Lefebvre
2011) to MEDLINE (Ovid) and adaptations of it to the other
databases, with the exception of CENTRAL. We will search all
databases from 1970 to the present, and we will impose no restric-
tion on language of publication.
Searching other resources
Wewill identify any relevant ongoing trials through searching trial
registers and trial result registers, which are the best sources for
trials that are either ongoing or unpublished:
• ClinicalTrials.gov (www.ClinicalTrials.gov);
• WHO International Clinical Trials Registry Platform
Search Portal (http://apps.who.int/trialsearch/);
• National Institute for Health Research search portal (https:/
/portal.nihr.ac.uk/Pages/NIHRResearchInfoStatement.aspx);
• UK Clinical Trials Gateway - Current Controlled Trials (
www.controlled-trials.com/ukctr/);
• National Research Register Archive (portal.nihr.ac.uk/
Pages/NRRArchive.aspx);
• University Hospital Medical Information Network Clinical
Trials Registry (www.umin.ac.jp/ctr/).
We will handsearch the reference list of all included studies, back-
ground articles and the narrative review articles described above,
to identify any additional relevant studies.
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We will search commercial and non-profit organisation websites
for additional information that may be relevant to us:
• HAES UK (http://www.healthateverysize.org.uk/);
• Association for Size Diversity and Health (https://
www.sizediversityandhealth.org/);
• National Association to Advance Fat Acceptance (NAAFA)
(http://www.naafaonline.com/dev2/);
• the resource list for the HAES curriculum (http://
haescurriculum.files.wordpress.com/2013/07/haes-curriculum-
resource-list.pdf).
Wewill keep andmaintain a hard or electronic copy of findings and
study details, with specific reference to the date when we accessed
the websites.
We will contact the authors of relevant papers where trials are
ongoing or data are missing.
Data collection and analysis
Selection of studies
NK and DL will check the titles and abstracts of studies generated
by the search. We will obtain full-text copies of papers reporting
relevant trials and have them translated if necessary. NK and DL
will independently review the trials, either accepting or rejecting
them in accordance with the eligibility criteria (Table 2). We will
resolve any disagreement regarding study inclusion through dis-
cussion with a third author (GF). In the case of different reports
of the same study, we will use the data only once.
Data extraction and management
For each trial, NK will extract the data and DL will check them.
We will use a data collection form to record the study methods,
participant characteristics and outcomes. We will present this in-
formation in a ’Characteristics of included studies’ table. The in-
formation collected will include the following.
Methods
• Design of the trial, for example RCT or cluster RCT
• Method of randomisation
• Method of randomisation concealment
• How participants were selected
• Details of ethical approval and when consent forms and
information sheets were given to participants
• The location and setting of the study
• The date of the study
• Total duration of the study
• Time elapsed before following up with participants or any
withdrawal of participants
• Details of any ’run in’ period used with HNWL or weight
loss programmes. For example, individuals may be required to
avoid weight loss attempts in the months preceding the trial
Participants
• The number of participants randomly assigned to each
intervention group
• Baseline demographic information relating to participants
(age, gender, ethnicity)
• Baseline BMI of participants
• Presence of comorbidities
• Whether having any treatment or taking any medication
that may influence the cardiovascular risk factors being measured
• Inclusion and exclusion criteria used in the study
Interventions
• Description and duration of any form of HNWL
programme used
• Aherence to the intervention
• Description and duration of any form of CWL programme
used
• Supplementary interventions (e.g. low calorie diets or
extreme exercise) that might result in weight loss of more than 1
kg/week
• Whether any other forms of intervention were used and
further details if relevant
• Details of any dietary, physical activity, psychological or
behavioural support provided to participants
• Behaviour change techniques, using the taxonomy of
behaviour change (Michie 2011), used in the control and
intervention groups
• Details of any HNWL philosophy discussed
• Details of who delivered the intervention
Outcomes
• Outcomes measured
• Tools and methods used to record outcomes and whether
these are validated
• Timepoints when outcomes were measured
• Whether intention-to-treat (ITT) analysis was used/how
dropout was dealt with in the analysis
• Dropout rates
• Reasons for withdrawal
• Details of any adverse events in each group
• Additional outcome results
• Amount of missing data in both groups
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Assessment of risk of bias in included studies
We will assess risk of bias using the guidelines given in the
Cochrane Handbook for Systematic Reviews of Interventions
(Higgins 2011). We will include assessments of the domains of
random sequence generation, allocation concealment and incom-
plete outcome data. NK will assess the risk of bias in each study.
DL will check this, and GFwill, if necessary, assist in resolving any
disputes that arise during this process.We will grade each potential
source as having a high, low or unclear risk of bias, and provide a
quote from the study report together with a justification for our
judgement in the ’Risk of bias’ table (Table 3). We will summarise
our ’Risk of bias’ judgements across different studies for each of
the domains listed. Where information on risk of bias relates to
unpublished data or to correspondence with a trialist, we will note
this in the ’Risk of bias’ table. We will also note any other type of
bias (e.g. where there are financial conflicts of interest).
When considering treatment effects, we will consider whether the
contributing studies have a high, low or unclear risk of bias.
Measures of treatment effect
Most of our outcomes (e.g. weight, blood pressure, lipids) will
be continuous data. We will analyse continuous data as mean
differences with 95% confidence intervals, in order to compare the
change in outcome between the intervention and control arms.
We will enter data presented as a scale with a consistent direction
of effect. We will narratively describe skewed data reported as
medians and interquartile ranges. Some of our outcomes may use
ordinal scales (e.g. measures of psychosocial well being, levels of
physical activity). Where possible (i.e. with scales of five or more
ordinal categories) we will treat these as continuous data. If there
is variation in the scales used to measure the same outcome, we
will analyse these outcomes using standardised mean differences
and 95% confidence intervals.
Unit of analysis issues
In the case of cluster RCTs we will either reduce the size of the trial
to its effective sample size by taking into account the intracluster
correlation coefficient or we will calculate an inflated standard
error, whichever is most appropriate to the trial.
Dealing with missing data
We will contact investigators or study sponsors in order to verify
key study characteristics and obtain missing numerical outcome
data where possible. Where this is not possible, and the missing
data are thought to introduce serious bias, we will explore the
impact of including such studies on the overall assessment of the
results using sensitivity analyses. It may be necessary to analyse
separately those studies that used ITT analyses from those that
carried out completer analyses.
Assessment of heterogeneity
We will identify and analyse inconsistencies across study results
through an examination of the forest plots. We will observe the
overlapping confidence intervals and will use the I² statistic to
measure the heterogeneity among trials in each analysis. Significant
heterogeneity will be defined as a P value of less than 0.05 for the
Chi2 statistic (Q). Heterogeneity will be described as a percentage
using the I² statistic (I2 = [(Q - degrees of freedom)/Q] x 100%).
If I2 is over 75% we will use a random-effects model and we will
provide the pooled estimate for this analysis.
Regardless of the model used, where there is significant hetero-
geneity we will explore possible causes through prespecified sub-
group analyses, as described below. We will pay particular atten-
tion to those studies that have a poor overlap of confidence inter-
vals.
Assessment of reporting biases
This is a controversial area of treatment for those with obesity
and some relevant studies may not have been published as a result
of this controversy. We will assess the risk of selective outcome
reporting across the studies using a funnel plot, if sufficient studies
are available.
Data synthesis
We will use the Mantel-Haneszel fixed-effect model for pooling
results provided there is no significant heterogeneity that would
prevent us doing so. We will deal with anticipated sources of het-
erogeneity by the appropriate use of standardised mean differences
and subgroup analyses.
Subgroup analysis and investigation of heterogeneity
We will stratify our findings according to outcomes and length of
follow up. We may also need to stratify our analyses to analyse
trial data separately, according to whether the intervention had
an element of enhanced care, which may influence the effect size
(e.g. weight loss medication), or where populations have specific
characteristics (e.g. eating disorders, female gender or a specific
ethnicity).
Sensitivity analysis
We plan to carry out sensitivity analyses to review the influence
of studies with a low risk of bias on our findings. We may need to
analyse separately those studies that used ITT analyses from those
that carried out completer analysis. We may also need to analyse
separately those trials that were cluster randomised.
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Table 1. The checklist for HNWL (health, not weight loss, focused) and conventional weight loss (CWL) programmes
HNWL programmes CWL programmes
• Primary focus on improving physical health and mental
well being
• No weight loss goals are set
• Weight monitoring does not form part of treatment
(although weight may be measured at beginning and end of
intervention for research purposes)
• Internal signals of hunger and satiety determine level of
energy consumption
• Participants are supported by sharing their common
experiences
• Participants are asked to complete coursework throughout
the process
• Groups are led by interveners, who organise activities to
raise awareness about biological, sociocultural and psychological
factors through discussion, lectures and exercises
• Educational and psychotherapeutic workshops are offered
to participants by qualified counsellors who focus on mental well
being
• Primary focus on weight loss
• Weight loss goals are set
• Regular weight monitoring is an important part of the
programme
• Energy consumption is planned to create a 500 Kcal to 600
Kcal deficit through, for example, calorie counting, point
system, portion sizes, meal plans, fat restriction
• Food restriction, exercise or a combination of both,
designed to achieve a weight loss of 0.5 kg to 1 kg/week
• Participants are supported by educational materials and
expert advice (e.g. understanding food labels)
• Participants are educated on behavioural change
techniques, cognitive restructuring and problem-solving skills to
help them reach their weight loss goal
• A focus on behavioural change to achieve healthy eating and increase physical activity are part of both types of programmes
Table 2. - The criteria for considering studies for review
Inclusion criteria Exclusion criteria
• RCTs with at least 3 months of follow up
• Published since 1970
• Must contain participants with a BMI >25 kg/m2
• Must contain participants aged 18 years or over
• Must contain a programme that promotes a healthy
behavioural change around eating and or physical activity,
without a focus on weight loss
• Must contain a programme focusing on weight loss
through behavioural change
• Outcomes include: blood lipids, blood pressure, fasting
blood glucose, waist-to-hip ratio, weight, depression, stress,
anxiety, change in diet, change in physical activity, eating
behaviours (cognitive dietary restraint, disinhibition and
susceptibility to hunger), self-esteem, body image or mental well
being
• Non-RCTs
• Observational studies
• RCTs with less than 3 months of follow up
• Published before 1970
• Participants have a BMI <25 kg/m2
• Participants aged less than 18 years only
• Without a programme that promotes a healthy behavioural
change around eating and or physical activity, without a focus on
weight loss
• Without a programme focusing on weight loss through
behavioural change
• Outcomes do not include: blood lipids, blood pressure,
fasting blood glucose, waist-to-hip ratio, weight, depression,
stress, anxiety, change in diet, change in physical activity, eating
behaviours (cognitive dietary restraint, disinhibition and
susceptibility to hunger), self-esteem, body image or mental well
being
BMI = body mass index
RCT = randomised controlled trial
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Table 3. - The Cochrane Collaboration’s tool for assessing risk of bias
Domain Support for judgement Review authors’ judgement
Selection bias
Random sequence generation Describe the method used to generate the
allocation sequence in sufficient detail to
allow an assessment of whether it should
produce comparable groups
Selection bias (biased allocation to inter-
ventions) due to inadequate generation of
a randomised sequence
Allocation concealment Describe the method used to conceal the
allocation sequence in sufficient detail to
determinewhether intervention allocations
could have been foreseen in advance of, or
during, enrolment
Selection bias (biased allocation to inter-
ventions) due to inadequate concealment
of allocations prior to assignment
Attrition bias
Incomplete outcome data Assessments
should be made for each main outcome (or
class of outcomes)
Describe the completeness of outcome data
for each main outcome, including attri-
tion and exclusions from the analysis. State
whether attrition and exclusions were re-
ported, the numbers in each intervention
group (compared with total randomised
participants), reasons for attrition/exclu-
sions where reported, and any re-inclusions
in analyses performed by the authors
Attrition bias due to amount, nature or
handling of incomplete outcome data
A P P E N D I C E S
Appendix 1. Preliminary search strategy - MEDLINE (Ovid)
1.“health at every size”.tw.
2.HAES.tw.
3.(weight adj4 (manag* or accept* or centred* or centered*)).tw.
4.(health* adj6 (size or weigh*)).tw
5.“Non diet*”.tw.
6.“non-diet*”.tw.
7.“nondiet*.tw.
8.(Wholistic or holistic) adj4 weight.tw.
9.((Intuitiv* or attentiv* or mindful*) adj4 eat*).tw.
10.or/1-9
11.exp Hypertension/
12.hypertensi*.tw.
13.blood pressure.tw.
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14.Blood Pressure/
15.Cholesterol/
16.cholesterol*.tw.
17.Cholesterol, HDL/
18.Cholesterol, LDL/
19.Triglycerides/
20.triglyceride*.tw.
21.triacylglycerol*.tw.
22.lipoprotein*.tw.
23.bmi.tw.
24.overweight.tw.
25.body mass index/
26.exp Abdominal Fat/
27.exp Overweight/
28.obes*.tw.
29.exp Obesity/
30.(weight adj2 (gain* or chang* or los* or maint*)).tw.
31.(body mass adj (index or indexes or indices)).tw.
32.abdominal fat.tw.
33.quetelet* index.tw.
34.((reduc* or increas* or decreas* or los* or gain*) adj2 weight).tw.
35.Body fat.tw.
36.Fat mass.tw.
37.Waist.tw.
38.Diet*.tw.
39.Intake.tw.
40.Consumption.tw.
41.exp food and beverages/
42.exp drinking behavior/
43.physical adj activit*.tw.
44.exp exercise/
45.exp Affective symptoms/
46.exp depression/
47.exp stress, psychological/
48.well-being.tw.
49.Binge*.tw.
50.Three-factor.tw.
51.Disinhibition.tw.
52.Hunger.tw.
53.Restraint.tw.
54.Psychological adj $stress.tw.
55.Body adj (image or satisfaction or dissatisfaction).tw.
56.or/11-55
57. randomized controlled trial.pt.
58. controlled clinical trial.pt.
59. randomized.ab.
60. placebo.ab.
61. drug therapy.fs.
62. randomly.ab.
63. trial.ab.
64. groups.ab.
65. 57 or 58 or 59 or 60 or 61 or 62 or 63 or 64
66. exp animals/ not humans.sh.
11Health, not weight loss, focused programmes versus conventional weight loss programmes for cardiovascular risk factors (Protocol)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
67. 65 not 66
68. 10 and 56
69. 67 and 68
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